PYRIDOSTIGMINE

Clinical Indication

Myasthenia gravis

Comments

Includes sustained release formulation (Mestinon Timespan).

Date of classification

May 2015

Review date

May 2015

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.